---
layout: post
title: New Drug Approvals 2013 - Pt. XXX -  Umeclidinium bromide and Vilanterol (Anoro
  Elliptaâ„¢)
date: '2014-03-19T09:52:00.000Z'
author: Sam Croset
tags:
- Oral Drugs
- Small Molecule Drugs
- Black Box Warning Drugs
- 2014 New Drugs
modified_time: '2014-03-21T14:07:00.393Z'
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-4350478385335181822
blogger_orig_url: http://chembl.blogspot.com/2014/03/new-drug-approvals-2013-pt-xxx.html
---

<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
</div>
<div style="margin-left: 1em; margin-right: 1em;">
</div>
<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
</div>
<div style="margin-left: 1em; margin-right: 1em;">
</div>
<br />
<br />
<div style="text-align: center;">
<img src="http://www.trademarkia.com/logo-images/glaxo-group-limited/anoro-ellipta-85831335.jpg" height="134" width="320" /></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://www.ebi.ac.uk/chembltools/autoiconlarge2/1,1,0,2,0,1,0,0,1,1" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="33" src="https://www.ebi.ac.uk/chembltools/autoiconlarge2/1,1,0,2,0,1,0,0,1,1" width="320" /></a></div>
<div style="text-align: center;">
<b><br /></b>
<b>ATC code</b>:&nbsp;<a href="http://www.whocc.no/atc_ddd_index/?code=R03AL03">R03AL03</a></div>
<div style="text-align: center;">
<b>Wikipedia</b>:&nbsp;<a href="http://en.wikipedia.org/wiki/Umeclidinium_bromide">Umeclidinium bromide</a>&nbsp;(and&nbsp;<span style="text-align: left;"><a href="http://en.wikipedia.org/wiki/Vilanterol">vilanterol</a>)</span></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div>
</div>
<br />
<div style="-webkit-text-stroke-width: 0px; color: black; font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: center; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;">
<div style="margin: 0px;">
<b>ChEMBL</b>:&nbsp;<a href="https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1187833">CHEMBL1187833</a>&nbsp;(and&nbsp;<a href="https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1198857">CHEMBL1198857</a>)</div>
<div style="margin: 0px;">
<br /></div>
</div>
On December 18, 2013, the FDA approved Anoro Ellipta for the once-daily, long-term maintenance treatment of airflow obstruction in patients with obstructive pulmonary disease (COPD). Anoro is a combination of umeclidinium (62.5 mcg - more details below) and vilanterol inhalation powder (25 mcg -&nbsp;<a href="http://chembl.blogspot.co.uk/2013/05/new-drug-approvals-2013-pt-viii.html">already approved&nbsp;in a different formulation</a>). Ellipta is the single inhaler device:<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
</div>
<br />
<div>
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.sec.gov/Archives/edgar/data/1080014/000110465913068581/g200842mqi001.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://www.sec.gov/Archives/edgar/data/1080014/000110465913068581/g200842mqi001.jpg" height="183" width="320" /></a></div>
<br /></div>
<div>
<div>
The majority of COPD cases are due to cigarette smoking and this lung disease is a leading cause of death in the United States. Patients affected by COPD experience breathing difficulties worsening with the time as well as chronic cough and chest tightness.<br />
<br /></div>
</div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div style="margin-left: 1em; margin-right: 1em;">
</div>
<br />
<div>
<b>Umeclidinium</b><br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://www.ebi.ac.uk/chembl/compound/displayimage_large/CHEMBL1187833" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="320" src="https://www.ebi.ac.uk/chembl/compound/displayimage_large/CHEMBL1187833" width="320" /></a></div>
Umeclidinium (also known as umeclidinium bromide, GSK573719A and GSK573719) is a small molecule with a molecular weight of 428.6 Da and AlogP of 3.34, 8 rotatable bounds and no Lipinski's rule of five violation.<br />
<br />
Molecular formula:&nbsp;C29H34NO2<br />
Canonical SMILES:&nbsp;OC(c1ccccc1)(c2ccccc2)C34CC[N+](CCOCc5ccccc5)(CC3)CC4<br />
Standard InChI: InChI=1S/C29H34NO2/c31-29(26-12-6-2-7-13-26,27-14-8-3-9-15-27)28-16-19-30(20-17-28,21-18-28)22-23-32-24-25-10-4-1-5-11-25/h1-15,31H,16-24H2/q+1<br />
Alternate form of the molecule in ChEMBL:&nbsp;<a href="https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL523299">CHEMBL523299</a><br />
<br />
<b>Mechanism of action</b><br />
<b><br /></b>
<br />
<div>
<div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;">
<br /></div>
<div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;">
<br /></div>
<div style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;">
<br /></div>
<div>
Anoro Ellipta relaxes the muscles located around the airways of the lung to increase the airflow in patients. This mechanism of action is mediated via umeclidinium,&nbsp;<a href="http://en.wikipedia.org/wiki/Anticholinergic">anticholinergic</a>&nbsp;stopping muscle tightening in combination with vilanterol, a long-acting&nbsp;<a href="https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL210">beta2-adrenergic</a>&nbsp;agonist (LABA).</div>
<div>
<br />
<b>Safety information</b><br />
<br />
The phase III trials for Anoro Ellipta included seven clinical studies, involving around 6,000 patients with COPD. The mainly reported side-effect were narrowing and obstruction of the respiratory airway (paradoxical bronchospasm), cardiovascular effects, increased pressure in the eyes (acute narrow-angle glaucoma), and worsening of urinary retention.<br />
<br />
Note that Anoro Ellipta is not indicated for the treatment of asthma and displays a boxed warning for this indication.<br />
<br />
Anoro Ellipta is manufactured by GlaxoSmithKline, Research Triangle Park, N.C.</div>
</div>
</div>
</div>
